Edap Tms (NASDAQ:EDAP) Upgraded to Hold by StockNews.com

Edap Tms (NASDAQ:EDAP) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Tuesday.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $19.00 price objective on shares of Edap Tms in a research note on Friday, May 17th.

Edap Tms Stock Up 1.5 %

Shares of Edap Tms stock traded up $0.08 during trading hours on Tuesday, reaching $5.30. The company’s stock had a trading volume of 8,568 shares, compared to its average volume of 37,273. Edap Tms has a one year low of $3.60 and a one year high of $9.53. The company has a market capitalization of $196.63 million, a P/E ratio of -9.81 and a beta of 0.45. The stock’s fifty day simple moving average is $6.07 and its two-hundred day simple moving average is $6.36. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.00 and a current ratio of 2.62.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings data on Thursday, May 16th. The medical equipment provider reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). Edap Tms had a negative net margin of 30.12% and a negative return on equity of 31.44%. The business had revenue of $16.13 million during the quarter, compared to the consensus estimate of $16.22 million. On average, research analysts forecast that Edap Tms will post -0.51 earnings per share for the current year.

Institutional Trading of Edap Tms

Several hedge funds have recently added to or reduced their stakes in EDAP. Virtu Financial LLC bought a new stake in Edap Tms in the first quarter worth about $82,000. Miracle Mile Advisors LLC bought a new stake in Edap Tms in the first quarter worth about $136,000. Roubaix Capital LLC bought a new stake in Edap Tms in the first quarter worth about $169,000. Finally, Rock Springs Capital Management LP raised its position in Edap Tms by 14.6% in the third quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock worth $9,547,000 after acquiring an additional 173,700 shares during the period. Institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.